Healthcare system model more effective than telephone quitline for tobacco cessation: JAMA

Written By :  Dr. Kamal Kant Kohli
Published On 2022-06-29 05:06 GMT   |   Update On 2022-06-29 05:06 GMT

A healthcare system model that offered tobacco cessation treatment to smokers being discharged from a hospital produced a higher rate of tobacco abstinence during the three-month program than referral to a state-based telephone quitline, but the advantage disappeared at six months when both treatments produced comparable quit rates, researchers from Massachusetts General Hospital (MGH)...

Login or Register to read the full article

A healthcare system model that offered tobacco cessation treatment to smokers being discharged from a hospital produced a higher rate of tobacco abstinence during the three-month program than referral to a state-based telephone quitline, but the advantage disappeared at six months when both treatments produced comparable quit rates, researchers from Massachusetts General Hospital (MGH) have found.

In a study in JAMA Internal Medicine, the team suggested that extension beyond three months of the health system approach, which includes cessation medication and telephone-based behavioral support, could potentially keep individuals tobacco-free.

"Hospital admission is a great opportunity for smokers to begin tobacco cessation treatment," says lead author Nancy Rigotti, MD, director of the MGH Tobacco Research and Treatment Center. "That treatment is only effective, however, if it continues after discharge. How to best meet that ongoing need is the question our study was designed to address."

Cigarette smoking is responsible for around 480,000 deaths annually, the leading cause of preventable deaths in the United States. In 2020, an estimated 13 percent of adults were regular smokers, and more than 3.2 million of them were admitted to a hospital. Researchers from MGH, Vanderbilt University Medical Center, and University of Pittsburgh Medical Center conducted a study of 1,409 adults who smoked and received brief in-hospital tobacco treatment at one of these medical centers to determine the most effective post-discharge model for cessation.

Participants were randomized to one of two models, each offering tobacco cessation medication and counseling by telephone for up to three months. One model used the national system of state-based telephone quitlines, which provides cessation counseling and free samples of nicotine patches, gum, or lozenges. The medical center model provided people who smoked with nicotine medications at hospital discharge and continued counseling with a series of automated and live phone calls.

The study found that three months after discharge, more participants in the healthcare system model were tobacco-free for at least seven days (which was biochemically verified), compared to the quitline model. But at six months-three months after healthcare system intervention ended- the difference in smoking abstinence rates between the two models had narrowed and was not statistically significant.

"Our findings prompt the question of whether continuing smoking cessation past three months-the standard duration of treatment-would sustain the superior results of the healthcare system model," says senior author Hilary Tindle, MD, MPH, founding director of the Vanderbilt Center for Tobacco Addiction and Lifestyle. "It's possible that more counseling or medication, or both, could generate more engagement with the program and thus better results over time."

For further reference:

Comparative Effectiveness of Postdischarge Smoking Cessation Interventions for Hospital Patients. Nancy A. Rigotti, MD1,2,3,4; Yuchiao Chang, PhD1,2,4; Esa M. Davis, MD, MPH5,6; et al Susan Regan, PhD1,2,4; Douglas E. Levy, PhD1,3,4; Thomas Ylioja, PhD7; Jennifer H. K. Kelley, RN, DNP1; Anna E. Notier, MSW5,6; Karen Gilliam, MA8; Antoine B. Douaihy, MD5,6; Daniel E. Singer, MD2,4; Hilary A. Tindle, MD, MPH8,9 http://dx.doi.org/10.1001/jamainternmed.2022.2300

Tags:    
Article Source : JAMA Internal Medicine

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News